Andrew Bialecki, co-CEO and director of Klaviyo (NASDAQ:KVYO), sold 212,529 shares of Series A Common Stock on May 26, 2026, for about $3.1 million. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 20, 2025.
The shares were sold at a weighted average price of $14.61, with individual trades between $14.43 and $15.00. The stock currently trades at $14.74, down 56% over the past year and 54.6% year-to-date.
The sale followed a conversion of Series B Common Stock into Series A shares. Each Series B share is convertible into one Series A share at any time. After these transactions, Bialecki directly holds 66,731,589 shares of Series B Common Stock.
He also has indirect holdings: 7,517,410 shares in a grantor trust, trusts for Elizabeth and Andrew, and 43,218 shares held by his spouse. He disclaims beneficial ownership of trust-held shares except for his pecuniary interest.
Klaviyo appears undervalued, trading near its 52-week low of $13.53. The company has a current ratio of 4.23 and holds more cash than debt.
In Q1 2026, Klaviyo beat estimates with EPS of $0.22 (vs. $0.20 expected) and revenue of $358M (vs. $348.6M expected). Analysts have lowered price targets: Stifel from $35 to $28, Piper Sandler from $30 to $26.
